Synthetic Toll-like Receptors 7 and 8 Agonists: Structure–Activity Relationship in the Oxoadenine Series

Synthetic Toll-like Receptors 7 and 8 Agonists: Structure–Activity Relationship in the Oxoadenine Series

Bibliographic Details
Main Authors:	Jay T. Evans, Laura S. Bess, Sandra C. Mwakwari, Mark T. Livesay, Yufeng Li, Van Cybulski, David A. Johnson, Hélène G. Bazin
Format:	Article
Language:	English
Published:	American Chemical Society 2019-09-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.9b02138

Similar Items

8-Oxoadenine: A «New» Player of the Oxidative Stress in Mammals?
by: Alexander A. Kruchinin, et al.
Published: (2024-01-01)

Novel Lipidated Imidazoquinoline TLR7/8 Adjuvants Elicit Influenza-Specific Th1 Immune Responses and Protect Against Heterologous H3N2 Influenza Challenge in Mice
by: Shannon M. Miller, et al.
Published: (2020-03-01)

Conformation of guanine-8-oxoadenine base pairs in the crystal structure of d(CGCGAATT(O8A)GCG).
by: Leonard, G, et al.
Published: (1992)

Polymer carriers of toll-like receptor-7/8 agonists as vaccine adjuvants
by: Lynn, G
Published: (2014)

Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants.
by: Arulkumaran Shanmugam, et al.
Published: (2012-01-01)

Toll-like receptor agonists as cancer vaccine adjuvants
by: Donghwan Jeon, et al.
Published: (2024-12-01)

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
by: Max E. Kirtland, et al.
Published: (2020-11-01)

Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants
by: Bhagchandani, Sachin, et al.
Published: (2021)

Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants
by: Bhagchandani, Sachin Haresh, et al.
Published: (2021)

Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells
by: Reinhard Dummer, et al.
Published: (2022-06-01)

The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
by: Lingling Huang, et al.
Published: (2022-06-01)

Anti-tumor Activity of Toll-Like Receptor 7 Agonists
by: Huju Chi, et al.
Published: (2017-05-01)

Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer
by: Christian Rolfo, et al.
Published: (2023-03-01)

Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver
by: Jo, J, et al.
Published: (2014)

Toll-Like Receptor 8 Agonist Strengthens the Protective Efficacy of ESAT-6 Immunization to Mycobacterium tuberculosis Infection
by: Jun Tang, et al.
Published: (2018-01-01)

Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver.
by: Juandy Jo, et al.
Published: (2014-06-01)

Antibody conjugates for targeted delivery of Toll-like receptor 9 agonist to the tumor tissue.
by: Diana Corogeanu, et al.
Published: (2023-01-01)

Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
by: Samik Chakraborty, et al.
Published: (2023-10-01)

Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments
by: Zhi-Mei Liu, et al.
Published: (2022-09-01)

Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists
by: Amanda B. Macedo, et al.
Published: (2019-10-01)

PROSPECTS OF Toll-LIKE RECEPTOR AGONISTS AND ANTAGONISTS FOR PREVENTION AND TREATMENT OF VIRAL INFECTIONS
by: A. A. Nikonova, et al.
Published: (2019-07-01)

Innate and Adaptive Responses of Intratumoral Immunotherapy with Endosomal Toll-Like Receptor Agonists
by: Fernando Torres Andón, et al.
Published: (2022-07-01)

PROSPECTS OF TOLL-LIKE RECEPTOR AGONISTS AND ANTAGONISTS FOR PREVENTION AND TREATMENT OF VIRAL INFECTIONS
by: Alexandra Alexandrovna Nikonova, et al.
Published: (2019-03-01)

Assessment of the Impact of a Toll-like Receptor 2 Agonist Synthetic Lipopeptide on Macrophage Susceptibility and Responses to African Swine Fever Virus Infection
by: Giulia Franzoni, et al.
Published: (2022-10-01)

Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation.
by: Karen A O Martins, et al.
Published: (2014-01-01)

Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity.
by: Gregory N Dietsch, et al.
Published: (2016-01-01)

Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants
by: Sudeep Kumar, et al.
Published: (2019-05-01)

A deimmunized and pharmacologically optimized Toll-like receptor 5 agonist for therapeutic applications
by: Vadim Mett, et al.
Published: (2021-04-01)

Immunostimulatory Phosphatidylmonogalactosyldiacylglycerols (PGDG) from the Marine Diatom <i>Thalassiosira weissflogii</i>: Inspiration for a Novel Synthetic Toll-Like Receptor 4 Agonist
by: Emiliano Manzo, et al.
Published: (2019-02-01)

Toll-Like Receptor 4 Expression on Lymphoma Cells Is Critical for Therapeutic Activity of Intratumoral Therapy With Synthetic TLR4 Agonist Glucopyranosyl Lipid A
by: Hailing Lu, et al.
Published: (2020-08-01)

Sequential acid/reduction response of triblock copolymeric nanomicelles to release camptothecin and toll-like receptor 7/8 agonist for orchestrated chemoimmunotherapy
by: Xiaoyan Ge, et al.
Published: (2022-08-01)

The Imidazoquinoline Toll-Like Receptor-7/8 Agonist Hybrid-2 Potently Induces Cytokine Production by Human Newborn and Adult Leukocytes.
by: Lakshmi Ganapathi, et al.
Published: (2015-01-01)

Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16− subset
by: Enrico Maggi, et al.
Published: (2022-01-01)

Expression of toll like receptor 8 (TLR8) in specific groups of mouse hippocampal interneurons.
by: Lennart Seizer, et al.
Published: (2022-01-01)

Epithelial immunomodulation by aerosolized Toll-like receptor agonists prevents allergic inflammation in airway mucosa in mice
by: David L. Goldblatt, et al.
Published: (2022-08-01)

Placental Toll-like receptor 3 and Toll-like receptor 7/8 activation contributes to preeclampsia in humans and mice.
by: Piyali Chatterjee, et al.
Published: (2012-01-01)

Engineering Therapeutic Strategies in Cancer Immunotherapy via Exogenous Delivery of Toll-like Receptor Agonists
by: Sehwan Jeong, et al.
Published: (2021-08-01)

Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases
by: Jing-Xing Yang, et al.
Published: (2022-02-01)

Extracellular Ribosomal RNA Acts Synergistically with Toll-like Receptor 2 Agonists to Promote Inflammation
by: Karsten Grote, et al.
Published: (2022-04-01)

3-(5-Hydroxyphenyl)-5-Phenyl-2-Pyrazolines as Toll-Like Receptor 7 Agonists
by: Ji Hwan Kim, et al.
Published: (2023-01-01)